Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis

Hong-li Yan1, Geng Xue, Qian Mei

  • 1Institute of Genetics, Second Military Medical University, Shanghai, China.

The EMBO Journal
|August 22, 2009
PubMed

Insights

The tumor suppressor p53 represses the miR-17-92 cluster under hypoxia, a key mechanism in controlling hypoxia-induced apoptosis and tumor suppression. This finding reveals a novel p53 target crucial for cellular response to low oxygen.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Biology

Background:

  • Hypoxia is a common feature in solid tumors, influencing tumor progression and therapeutic response.
  • The p53 tumor suppressor protein plays a critical role in cellular stress responses, including those induced by hypoxia.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various cellular processes, including apoptosis and cancer.

Purpose of the Study:

  • To investigate the role of the miR-17-92 cluster in hypoxia-induced apoptosis.
  • To identify novel targets of p53-mediated transcriptional repression under hypoxic conditions.
  • To elucidate the regulatory mechanism of miR-17-92 expression by p53 in the context of hypoxia and cancer.

Main Methods:

  • Cell culture under normoxic and hypoxic conditions.
  • Analysis of miR-17-92 cluster expression in wild-type p53 and p53-deficient cells.
  • Luciferase reporter assays to map p53-binding sites on the miR-17-92 promoter.
  • Chromatin immunoprecipitation (ChIP) and Re-ChIP assays to study protein-DNA interactions.
  • Gel retardation assays to assess p53 and TATA-binding protein (TBP) competition.
  • Analysis of pri-miR-17-92 expression in colorectal carcinoma tissues.
  • Functional studies involving overexpression or inhibition of miR-17-92 components.

Main Results:

  • Hypoxia treatment led to reduced miR-17-92 cluster expression in cells with wild-type p53, but not in p53-deficient cells.
  • p53 directly represses miR-17-92 transcription via a binding site in its proximal promoter, independent of c-Myc.
  • p53 and TBP binding sites on the miR-17-92 promoter overlap, indicating competition for binding.
  • Pri-miR-17-92 expression levels correlated with p53 status in colorectal carcinomas.
  • Overexpression of the miR-17-92 cluster inhibited hypoxia-induced apoptosis, while blocking miR-17-5p and miR-20a sensitized cells to apoptosis.

Conclusions:

  • The miR-17-92 cluster is a novel target of p53-mediated transcriptional repression under hypoxia.
  • p53-mediated repression of miR-17-92 plays a significant role in regulating hypoxia-induced apoptosis.
  • This regulatory axis contributes to the tumor-suppressive functions of p53, offering insights into cancer biology and potential therapeutic strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...